NEVVI Medicare utilization intelligence
+ Build a code basket
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS
J9250 Methotrexate sodium, 5 mg HCPCS · Chemotherapy treatment
Classification Treatment Chemotherapy Chemotherapeutic Agent (CMS RBCS)
First observed 2013 — start of our 12-year window; the code predates it
National scale 11,311 services ▼ 79.4% YoY · 675 beneficiaries (CY2024, Medicare FFS)
Medicare paid $2K · $0.21 avg / service, national
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Billing groups
10
Named-group FFS services
5,850
FFS of Medicare
49%
Services YoY
-79.4%
FFS enrollment -2.2%
Estimated all-Medicare volume FFS + estimated MA estimate
~10,912 services

5,850 observed fee-for-service (54%) · ~5,062 estimated Medicare Advantage. Scaled from the observed floor by each state’s fee-for-service share (FFS share as of 2024) — scaled estimate — assumes MA utilization mirrors FFS; not an observation. How we scale

Top states — J9250 (CY2024)

Disclosed Medicare fee-for-service services by billing state; open a bar for that state's ranked market.

Named-group submitted charges
$23K
Named-group allowed amount
$2K
Named-group Medicare payments
$1K
Avg charge / svc
$4
Avg allowed / svc
$0
Avg payment / svc
$0
Average charge per group
$1 10 groups · avg submitted charge / service $25
Market analyticsPlatform
a taste of the twelve-year trend layer

Or just look at it: nuclear heart imaging (78452) in Arizona is open as a live example — the full paid view, real data.

View the live example →

Nevvi's market analytics platform — code baskets, market structure and share, the twelve-year trend layer — is built and not launched yet. We're gathering interest in it.

Notify me at launch →
Refine: group size any 5+ 25+ 100+ independent only
Filter results:

Email me this CSV

Data year: CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Physician groups ranked by J9250 services, highest first, CY2024
# Physician group activate to sort City activate to sort St activate to sort Specialty activate to sort Providers activate to sort J9250 svcs sorted descending — activate to reverse Submitted charges activate to sort Avg charge activate to sort Medicare $ locked column Share* activate to sort Phone
1 MASS GENERAL BRIGHAM MEDICAL GROUP NORTHERN MASSACHUSETTS INC SALEM MA NURSE PRACTITIONER 803 1,829 $1,819 $1 premium 50.6% (978) 741-4133
2 RHEUMATOLOGY AND INTERNAL MEDICINE ASSOCIATES PC WILMINGTON MA INTERNAL MEDICINE 3 1,065 $5,325 $5 premium 29.5% (978) 988-9700
3 LEBANON INTERNAL MEDICINE ASSOCIATES PC LEBANON PA PHYSICIAN ASSISTANT 17 999 $2,790 $3 premium 49.6% (717) 273-6706
4 THE ARTHRITIS AND DIABETES CLINIC INC MONROE LA NURSE PRACTITIONER 4 746 $1,125 $2 premium 100.0% (318) 388-5830
5 INLAND RHEUMATOLOGY AND OSTEOPOROSIS MEDICAL GROUP INC UPLAND CA RHEUMATOLOGY 4 419 $5,447 $13 premium 62.5% (909) 982-0099
6 MARC J HIRSH MD PA DELRAY BEACH FL RHEUMATOLOGY 9 252 $176 $1 premium 12.6% (561) 819-3100
7 ARTHRITIS ASSOCIATES OF S FLORIDA DELRAY BEACH FL RHEUMATOLOGY 6 220 $1,100 $5 premium 11.0% (561) 495-0600
8 CORA HEALTH SERVICES INC THE VILLAGES FL ORTHOPEDIC SURGERY 1187 154 $924 $6 premium 7.7% (352) 693-3378
9 NEWPORT HUNTINGTON MEDICAL GROUP HUNTINGTON BEACH CA RHEUMATOLOGY 5 144 $3,600 $25 premium 21.5% (714) 378-2421
10 JACKSON CENTER, PA. NAPLES FL DERMATOLOGY 4 22 $440 $20 premium 1.1% (239) 598-9009

*Share of the state's disclosed Medicare-FFS services for the primary code, counted once per clinician. "St" is the state the volume was billed from: a group appears in each state where its clinicians bill Medicare, with that state's volume and share ("City" is the group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group, so shares reflect attributable volume. See Methods.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix. Modeled all-payer databases project the remainder statistically; we publish the audited floor and label it as such. Same market, different denominator. How the numbers reconcile →